Genomic Scan of 254 Hereditary Prostate Cancer Families

Prostate

Volumn 57, Issue 4, 2003, Pages 309-319

  Janer, Marta ^a   Friedrichsen, Danielle M ^b   Stanford, Janet L ^b,c   Badzioch, Michael D ^d   Kolb, Suzanne ^b   Deutsch, Kerry ^a   Peters, Mette A ^b   Goode, Ellen L ^c,d   Welti, Russ ^a   DeFrance, Hawkins B ^b   Iwasaki, Lori ^b   Li, Sarah ^a   Hood, Leroy ^a   Ostrander, Elaine A ^b,e   Jarvik, Gail P ^c,d,e,f  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Brain cancer; Genetic susceptibility; Heterogeneity; Linkage analysis; Ovarian cancer; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CANCER; CELL HETEROGENEITY; CHROMOSOME 17P; CHROMOSOME 6P; CHROMOSOME 7Q; CLINICAL FEATURE; COMORBIDITY; FAMILIAL CANCER; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BRAIN NEOPLASMS; BREAST NEOPLASMS; DNA, NEOPLASM; FAMILY; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0344512366     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10305     Document Type: Article

References (75)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53(1):5-26.
2. Morganti G, Gianferrari L, Cresseri A, Arrigoni G, Lovati G. Recherches clinico-statistiques et genetiques sur les neoplasies de la prostate. Acta Genetica 1956;6:304-305.
3. Woolf CM. An investigation of the familial aspects of carcinoma of the prostate. Cancer 1960;13:739-744.
4. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. In: Bodmer W, editor. Inheritance of susceptibility to cancer in man. New York: Oxford University Press; 1982. pp 47-69.
5. Steinberg G, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990;17(4):337-347.
6. Grönberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994;152:1484-1487.
7. Grönberg H, Damber L, Damber JE. Total food consumption and body mass index in relation to prostate cancer risk: A case-control study in Sweden with prospectively collected exposure data. J Urol 1996b;155(3):969-974.
8. Whittemore A, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, Burch JD, Hankin J, Dreon DM, West DW. Prostate cancer in relation to diet, physical activity, and body size in Blacks, Whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995b;87(9):652-661.
9. Page WF, Braun MM, Partin AW, Caporaso N, Walsh P. Heredity and prostate cancer: A study of World War II veteran twins. Prostate 1997;33(4):240-245.
10. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer-Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343(2):78-85.
11. Carter B, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89(8):3367-3371.
12. Grönberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: Support for dominant inheritance. Am J Epidem 1997b;146(7):552-557.
13. Schaid D, McDonnell SK, Blute ML, Thibodeau SN. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998;62:1425-1438.
14. Monroe K, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1995;1(8):827-829.
15. Narod S, Dupont A, Cusan L, Diamond P, Gomez JL, Suburu R, Labrie F. The impact of family history on early detection of prostate cancer. Nat Med 1995a;1(2):99-101.
16. Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001;68(5):1207-1218.
17. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Segregation analysis of prostate cancer in 1,719 White, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13(5):471-482.
18. Conlon E, Goode EL, Gibbs M, Stanford JL, Badzioch M, Janer M, Kolb S, Hood L, Ostrander EA, Jarvik GP, Wijsman EM. Oligogenic segregation analysis of hereditary prostate cancer pedigrees: Evidence for multiple loci affecting age at onset. Int J Cancer 2003;105(5):630-635.
19. Smith J, Freije D, Carpten JD, Grönberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-1374.
20. Cooney K, McCarthy JD, Lange E, Huang L, Miesfeldt S, Montie JE, Oesterling JE, Sandler HM, Lange K. Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study. J Natl Cancer Inst 1997;89(13):955-959.
21. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS. A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet 2001;69(1):148-158.
22. Grönberg H, Xu J, Smith JR, Carpten JD, Isaacs SD, Freije D, Bova GS, Walsh PC, Collins FS, Trent JM, Meyers DA, Isaacs WB. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. Cancer Res 1997c;57(21):4707-4709.
23. Xu G, International Consortium for Prostate Cancer Genetics. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66(3):945-947.
24. McIndoe R, Stanford JL, Gibbs M, Jarvik GP, Brandzel S, Neal CL, Li S, Gammack JT, Gay AA, Goode EL, Hood L, Ostrander EA. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997;61:347-353.
25. Eeles R, Durocher F, Edwards S, Teare D, Badzioch M, Hamoudi R, Gill S, Biggs P, Dearnaley D, Ardern Jones A, Dowe A, Shearer R, McLennan DL, Norman RL, Ghadirian P, Aprikian A, Ford D, Amos C, King TM, The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Labrie R, Simard J, Narod SA, Easton D, Foulkes WD. Linkage analysis of chromosome 1q markers in 136 prostate cancer families. Am J Hum Genet 1998;62:653-658.
26. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wöhr G, Latil A, Millasseau P, Mellah I, Cohen N, Blanché H, Bellané -Chantelot C, Demenais F, Teillac P, Le Duc A, de Petriconi R, Hautmann R, Chumakov I, Bachner L, Maitland NJ, Lidereau R, Vogel W, Fournier G, Mangin P, Cohen D, Cussenot C. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am J Hum Genet 1998;62:1416-1424.
27. Goode E, Stanford JL, Chakrabarti L, Gibbs M, Kolb S, McIndoe RA, Buckley VA, Schuster EF, Neal CL, Miller EL, Brandzel S, Hood L, Ostrander EA, Jarvik GP. Linkage analysis of 150 high-risk prostate cancer families at 1q24-25. Genet Epidemiol 2000;18(3):251-275.
28. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y, Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Gronberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30(2):181-184.
29. Gibbs M, Stanford JL, McIndoe RA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L, Ostrander EA. Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999b;64:776-787.
30. Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Trent J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 1998;20(2):175-179.
31. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ. Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 2000;67(1):82-91.
32. Peters M, Jarvik GP, Janer M, Chakrabarti L, Kolb S, Goode EL, Gibbs M, DuBois CC, Schuster EF, Hood L, Ostrander EA, Stanford JL. Genetic linkage analysis of prostate cancer families to Xq27-28. Hum Hered 2001;51:107-113.
33. Bock C, Cunningham JM, McDonnell SK, Schaid DJ, Peterson BJ, Pavlic RJ, Schroeder JJ, Klein J, French AJ, Marks A, Thibodeau SN, Lange EM, Cooney KA. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet 2001;68(3):795-801.
34. Gibbs M, Stanford JL, Jarvik GP, Janer M, Badzioch M, Peters MA, Goode EL, Kolb S, Chakrabarti L, Shook M, Basom R, Ostrander EA, Hood L. A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 2000;67(1):100-109.
35. Suarez B, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC, Catalona WJ. A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000a;66(3):933-944.
36. Witte J, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ. Genome-wide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67(1):92-99.
37. Goddard K, Witte JS, Suarez BK, Catalona WJ, Olson JM. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001;68(5):1197-1206.
38. Slager S, Schaid DJ, Cunningham JM, McDonnell SK, Marks AF, Peterson BJ, Hebbring SJ, Anderson S, French AJ, Thibodeau SN. Confirmation of linkage of prostate cancer aggressiveness with chromosome 19q. Am J Hum Genet 2003;72(3):759-762.
39. Jarvik G, Stanford JL, Goode EL, McIndoe R, Kolb S, Gibbs M, Hood L, Ostrander EA. Confirmation of prostate cancer susceptibility genes using high risk families. Monogr Nat Canc Inst 1999;26:81-88.
40. Hall J, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990;250(4988):1684-1689.
41. Schellenberg G, Bird TD, Wijsman EM, Orr HT, Anderson LL, Nemens E, White JA, Bonnycastle L, Weber JL, Alonso ME, Potter H, Heston LL, Martin GM. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258(5082):668-671.
42. Schellenberg G. Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci USA 1995;92(19): 8552-8559.
43. Carter B, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, Walsh PC. Hereditary prostate cancer: Epidemiologic and clinical features. J Urol 1993;150(3):797-802.
44. Isaacs S, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87(13):991-996.
45. Goldgar D, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86(21):1600-1608.
46. Macklin M. The genetic basis of human mammary cancer. In: Proceedings of the Second national Cancer Conference 1954. 1074-1087.
47. Anderson D, Badzioch MD. Familial effects of prostate and other cancers on lifetime breast cancer risk. Breast Cancer Res Treat 1993;28(2):107-113.
48. Jishi M, Itnyre JH, Oakley-Girvan IA, Piver MS, Whittemore AS. Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1995;76(8):1416-1421.
49. Valeri A, Azzouzi R, Drelon E, Delannoy A, Mangin P, Fournier G, Berthon P, Cussenot O. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 2000;45(1):66-71.
50. Dong J, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886.
51. Bratt O, Kristoffersson U, Lundgren R, Olsson H. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: A population-based cohort study. Eur J Cancer 1997;33(13):2237-2240.
52. Damber L, Grönberg H, Damber JE. Familial prostate cancer and possible associated malignancies: Nation-wide register cohort study in Sweden. Int J Cancer 1998;78(3):293-297.
53. Grönberg H, Isaacs SD, Smith JR, Carpten JD, Bova GS, Freije D, Xu J, Meyers DA, Collins FS, Trent JM, Walsh PC, Isaacs WB. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA 1997;278(15):1251-1255.
54. Love R, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis 1985;38(4):289-293.
55. Airewele G, Adatto P, Cunningham J, Mastromarino C, Spencer C, Sharp M, Sigurdson A, Bondy M. Family history of cancer in patients with glioma: A validation study of accuracy. J Natl Cancer Inst 1998;90(7):543-544.
56. Sambrook J, Fritsch EF, Maniatis T. Isolation of high-molecular weight DNA from mammalian cells. In: Nolan C, editor. Molecular cloning: A laboratory manual, 2nd edn, Vol. 2. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989:pp 16-19.
57. O'Connell J, Weeks DE. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63(1):259-266.
58. Boehnke M, Cox NJ. Accurate inference of relationships in sibpair linkage studies. Am J Hum Genet 1997;61(2):423-429.
59. Sun L, Wilder K, McPeek MS. Enhanced pedigree error detection. Hum Hered 2002;54(2):99-110.
60. Friedman L, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8(4):399-404.
61. Kirkpatrick H, Waber P, Hoa-Thai T, Barnes R, Osborne-Lawrence S, Truelson J, Nisen P, Bowcock A. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene 1997;14(18):2189-2193.
62. Malone K, Daling JR, Thompson JD, O'Brien CA, Francisco LV, Ostrander EA. BRCA1 mutations and breast cancer in the general population: Analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 1998;279(12):922-929.
63. Wagner T, Stoppa-Lyonnet D, Fleischmann E, Muhr D, Pages S, Sandberg T, Caux V, Moeslinger R, Langbauer G, Borg A, Oefner P. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 1999;62(3): 369-376.
64. Clerget-Darpoux F, Bonaiti-Pellie C, Hochez J. Effects of misspecifying genetic parameters in LOD score analysis. Biometrics 1986;42:393-399.
65. Lathrop G, Lalouel JM, Lulier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984;81:3443-3446.
66. Cottingham R Jr., Idury RM, Schaffer AA. Faster sequential genetic linkage computations. Am J Hum Genet 1993;53(1):252-263.
67. Schaffer A, Gupta SK, Shriram K, Cottingham RW Jr. Avoiding recomputation in linkage analysis. Hum Hered 1994;44(4):225-237.
68. Ott J. Linkage probability and its approximate confidence interval under possible heterogeneity. Genet Epidemiol Suppl 1986;1:251-257.
69. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996;58(6):1347-1363.
70. Kruglyak L, McAllister L. Who needs genetic markers? [news; comment; see comments]. Nat Genet 1998;18(3):200-202.
71. Markianos K, Daly MJ, Kruglyak L. Efficient multipoint linkage analysis through reduction of inheritance space. Am J Hum Genet 2001;68(4):963-977.
72. Badzioch M, Eeles R, Leblanc G, Foulkes WD, Giles G, Edwards S, Goldgar D, Hopper J, Bishop DT, Møller P, Heimdal K, Easton D, The CRC/BPG UK Familial Prostate Cancer Study coordinators and collaborators, The EU Biomed collaborators, Simard J. Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. J Med Genet 2000;37:947-949.
73. Xu J, Zheng SL, Chang B, Smith JR, Carpten JD, Stine OC, Isaacs SD, Wiley KE, Henning L, Ewing C, Bujnovszky P, Bleeker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB. Linkage of prostate cancer susceptibility loci to chromosome 1. Hum Genet 2001;108(4):335-345.
74. Chu L, Troncoso P, Johnston DA, Liang JC. Genetic markers useful for distinguishing between organ-confined and locally advanced prostate cancer. Genes Chromosomes Cancer 2003;36(3):303-312.
75. Kasahara K, Taguchi T, Yamasaki I, Kamada M, Yuri K, Shuin T. Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. Cancer Genet Cytogenet 2002;137(1):59-63.